Keystone Financial Group Teva Pharmaceutical Industries LTD Transaction History

Keystone Financial Group

$274 Million
Q2 2024

A detailed history of Keystone Financial Group transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Keystone Financial Group holds 43,004 shares of TEVA stock, worth $735,798. This represents 0.26% of its overall portfolio holdings.

Number of Shares

43,004

Previous 45,404 5.29%

Holding current value

$735,798

Previous $640,000 9.06%

% of portfolio

0.26%

Previous 0.09%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 31, 2024	SELL	$12.78 - $17.4 $30,672 - $41,760	-2,400 Reduced 5.29%	43,004 $698,000
Q1 2024 May 08, 2024	SELL	$10.67 - $14.43 $10,136 - $13,708	-950 Reduced 2.05%	45,404 $640,000
Q4 2023 Feb 09, 2024	SELL	$8.12 - $10.63 $7,307 - $9,567	-900 Reduced 1.9%	46,354 $483,000
Q3 2023 Nov 06, 2023	SELL	$7.48 - $10.7 $9,724 - $13,909	-1,300 Reduced 2.68%	47,254 $481,000
Q2 2023 Aug 07, 2023	SELL	$7.2 - $9.47 $2,880 - $3,788	-400 Reduced 0.82%	48,554 $365,000
Q4 2022 Feb 07, 2023	SELL	$7.95 - $9.48 $2,385 - $2,844	-300 Reduced 0.61%	48,954 $446,000
Q3 2022 Nov 10, 2022	BUY	$6.86 - $11.95 $19,948 - $34,750	2,908 Added 6.27%	49,254 $397,000
Q2 2022 Aug 05, 2022	SELL	$7.38 - $10.4 $18,450 - $26,000	-2,500 Reduced 5.12%	46,346 $349,000
Q1 2022 May 13, 2022	BUY	$7.33 - $9.39 $9,162 - $11,737	1,250 Added 2.63%	48,846 $459,000
Q4 2021 Feb 11, 2022	SELL	$7.9 - $10.19 $1,580 - $2,038	-200 Reduced 0.42%	47,596 $381,000
Q3 2021 Nov 12, 2021	BUY	$8.38 - $10.18 $26,816 - $32,576	3,200 Added 7.18%	47,796 $466,000
Q2 2021 Aug 13, 2021	BUY	$9.9 - $11.56 $43,560 - $50,864	4,400 Added 10.95%	44,596 $442,000
Q4 2020 Feb 10, 2021	SELL	$8.61 - $11.04 $23,247 - $29,807	-2,700 Reduced 6.29%	40,196 $388,000
Q3 2020 Nov 13, 2020	BUY	$8.57 - $12.69 $12,126 - $17,956	1,415 Added 3.41%	42,896 $386,000
Q2 2020 Aug 13, 2020	BUY	$8.12 - $13.12 $3,532 - $5,707	435 Added 1.06%	41,481 $511,000
Q1 2020 May 05, 2020	BUY	$6.69 - $13.45 $18,063 - $36,315	2,700 Added 7.04%	41,046 $369,000
Q4 2019 Feb 06, 2020	SELL	$6.53 - $10.72 $5,877 - $9,648	-900 Reduced 2.29%	38,346 $376,000
Q3 2019 Nov 07, 2019	BUY	$6.16 - $9.6 $53,284 - $83,040	8,650 Added 28.27%	39,246 $270,000
Q2 2019 Aug 07, 2019	BUY	$8.12 - $15.72 $28,622 - $55,413	3,525 Added 13.02%	30,596 $282,000
Q1 2019 May 07, 2019	SELL	$15.58 - $20.01 $2,882 - $3,701	-185 Reduced 0.68%	27,071 $424,000
Q4 2018 Feb 11, 2019	SELL	$14.59 - $23.84 $7,513 - $12,277	-515 Reduced 1.85%	27,256 $420,000
Q2 2018 Aug 14, 2018	BUY	$16.77 - $24.71 $67 - $98	4 Added 0.01%	27,771 $680,000
Q1 2018 May 15, 2018	BUY	$16.68 - $22.07 $20,850 - $27,587	1,250 Added 4.71%	27,767 $466,000
Q4 2017 Feb 09, 2018	BUY	$11.23 - $19.1 $297,785 - $506,474	26,517	26,517 $507,000

Others Institutions Holding TEVA

# of Institutions

624

Shares Held

565M

Call Options Held

25.2M

Put Options Held

5.08M

View Full List

About TEVA PHARMACEUTICAL INDUSTRIES LTD

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $19B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

More about TEVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Keystone Financial Group, based on Form 13F filings with the SEC.

News

Stay updated on Keystone Financial Group with notifications on news.

Account

Keystone Financial Group Teva Pharmaceutical Industries LTD Transaction History